Growing Photomedicine Adoption Will Unlock Global Patient Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
16 Jul 25
Updated
08 Aug 25
AnalystHighTarget's Fair Value
AU$39.82
69.0% undervalued intrinsic discount08 Aug
AU$12.35
1Y
-12.8%7D
0.6%